Valerie Mbella
Company: Johnson & Johnson Innovative Medicine
Job title: Director, Global Regulatory Affairs
Seminars:
Chair’s Closing Remarks 4:30 pm
day: Day Two PM
Panel Discussion: Balancing Innovation & Compliance in Diagnostic Testing Amidst the Final LDT Rule to Ensure Patient Access to Great Drugs 8:30 am
Debating the positive and negative aspects of the Final LDT Rule for liquid biopsy innovation Understanding the responsibilities for drug-diagnostic partnerships in ensuring swift approvals How can we minimize financial and temporal burdens of complex approvals in the US?Read more
day: Day Two AM
Chair’s Opening Remarks 8:20 am
day: Day Two AM